Literature DB >> 26552568

Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy.

Elles J T M van der Louw1, Raakhee Desadien2, Florianne O L Vehmeijer2, Heleen van der Sijs3, Coriene E Catsman-Berrevoets2, Rinze F Neuteboom2.   

Abstract

PURPOSE: Anti-epileptic drugs (AEDs) and the ketogenic diet (KD) are often used concomitantly in children with refractory epilepsy. It has been hypothesised that certain AEDs may interfere with KD. The purpose of this study was to elucidate relationships between efficacy of KD and use of specific AEDs.
METHODS: A retrospective study was performed in 71 children with refractory epilepsy starting the KD between 2008 and 2014 in Erasmus University Hospital Sophia Children's Hospital. Efficacy of the KD (defined as 50% seizure reduction) was evaluated after three months of treatment and related to the AEDs used.
RESULTS: The KD was successful after three months in 61% of the children (N=71). Efficacy was significantly reduced if children (n=16) used lamotrigine (31%) at diet initiation or in the course of the diet, compared to other antiepileptic drugs (69%) (p=0.006). In comparison to children using other antiepileptic drugs, the percentage of children that had adequate ketosis was significantly reduced in case of lamotrigine use (p=0.049).
CONCLUSION: Lamotrigine treatment during KD is associated with a decreased efficacy of the KD.
Copyright © 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiepileptic drugs; Children; Efficacy; Epilepsy; Ketogenic diet; Lamotrigine

Mesh:

Substances:

Year:  2015        PMID: 26552568     DOI: 10.1016/j.seizure.2015.09.007

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

Review 1.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

Review 2.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

3.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Authors:  Eric H Kossoff; Beth A Zupec-Kania; Stéphane Auvin; Karen R Ballaban-Gil; A G Christina Bergqvist; Robyn Blackford; Jeffrey R Buchhalter; Roberto H Caraballo; J Helen Cross; Maria G Dahlin; Elizabeth J Donner; Orkide Guzel; Rana S Jehle; Joerg Klepper; Hoon-Chul Kang; Danielle A Lambrechts; Y M Christiana Liu; Janak K Nathan; Douglas R Nordli; Heidi H Pfeifer; Jong M Rho; Ingrid E Scheffer; Suvasini Sharma; Carl E Stafstrom; Elizabeth A Thiele; Zahava Turner; Maria M Vaccarezza; Elles J T M van der Louw; Pierangelo Veggiotti; James W Wheless; Elaine C Wirrell
Journal:  Epilepsia Open       Date:  2018-05-21

4.  Incidence of potential adverse events during hospital-based ketogenic diet initiation among children with drug-resistant epilepsy.

Authors:  Ali Mir; Raidah Albaradie; Abdullah Alamri; Mohammed AlQahtani; Entisar Hany; Aqeel Hussain; Mary Joseph; Shahid Bashir
Journal:  Epilepsia Open       Date:  2020-11-25

5.  Prospective control study of efficacy and influencing factors of a ketogenic diet on refractory epilepsy in children.

Authors:  Lianying Feng; Juan Wang; Xiujuan Li; Yue Hu; Siqi Hong; Li Jiang
Journal:  Transl Pediatr       Date:  2022-01

6.  Analysis of Factors That May Affect the Effectiveness of Ketogenic Diet Treatment in Pediatric and Adolescent Patients.

Authors:  Anna Winczewska-Wiktor; Adam Sebastian Hirschfeld; Magdalena Badura-Stronka; Paulina Komasińska-Piotrowska; Barbara Steinborn
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.